COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,009 Articles (22,627 medRxiv, 8,382 bioRxiv)

Most recent first Previous |  Page 1570: Articles 15691-15700  | Next

Previous COVID-19 infection but not Long-COVID is associated with increased adverse events following BNT162b2/Pfizer vaccination
Raw, R. K., Kelly, C., Rees, J., Wroe, C., Chadwick, D. R.
10.1101/2021.04.15.21252192 — Posted: 2021-04-22
Post-vaccination SARS-CoV-2 infections and incidence of the B.1.427/B.1.429 variant among healthcare personnel at a northern California academic medical center
Jacobson, K. B., Pinsky, B., Montez Rath, M. E., Wang, H., Miller, J. A., Skhiri, M., Shepard, J., Mathew, R., Lee, G., Bohman, B., Parsonnet, J., Holubar, M.
10.1101/2021.04.14.21255431 — Posted: 2021-04-22
Strategies for COVID-19 vaccination under a shortage scenario: a geo-stochastic modelling approach.
Barreiro, N. L., Ventura, C. I., Govezensky, T., Nunez, M., Bolcatto, P. G., Barrio, R. A.
10.1101/2021.04.19.21255745 — Posted: 2021-04-22
Evolution of case fatality rates in the second wave of coronavirus in England: effects of false positives, a Variant of Concern and vaccination.
Ackland, J. A., Ackland, G. J., Wallace, D. J.
10.1101/2021.04.14.21255385 — Posted: 2021-04-22
Preexisting and new-onset diabetes in patients with COVID-19 pneumonia
Laurenzi, A., Caretto, A., Molinari, C., Bazzigaluppi, E., Brigatti, C., Marzinotto, I., Mercalli, A., Melzi, R., Nano, R., Tresoldi, C., Landoni, G., Ciceri, F., Lampasona, V., Scavini, M., Piemonti, L.
10.1101/2021.04.17.21255548 — Posted: 2021-04-22
Comparison of SARS-CoV-2 serological assays for use in epidemiological surveillance in Scotland
McDonald, L., Wise, H., Muecksch, F., Poston, D., Mavin, S., Templeton, K., Furrie, E., Richardson, C., McGuire, J., Jarvis, L., Malloy, K., McAuley, A., Palmateer, N., Dickson, E., Hatziioannou, T., Bieniasz, P., Jenks, S.
10.1101/2021.04.20.21255596 — Posted: 2021-04-22
Single dose of BNT162b2 mRNA vaccine against SARS-CoV2 induces neutralizing antibody and polyfunctional T-cell responses in patients with CML
Harrington, P., Doores, K., Radia, D., O'Reilly, A., Lam, H. P. J., Seow, J., Graham, C., Lechmere, T., McLornan, D., Dillon, R., Shanmugharaj, Y., Espehana, A., Woodley, C., Saunders, J., Curto-Garcia, N., O'Sullivan, J., Kordasti, S., Malim, M. H., Harrison, C., de Lavallade, H.
10.1101/2021.04.15.21255482 — Posted: 2021-04-22
ReCOVer study: A Cross-sectional Observational Study to Identify the Rehabilitation Need in Post-discharge COVID-19 Survivors
Swarnakar, R., Yadav, S. L., V, S., Soni, K. D., Aggrawal, R., Trikha, A.
10.1101/2021.04.19.21255750 — Posted: 2021-04-22
B and T cell immune responses elicited by the BNT162b2 (Pfizer BioNTech) COVID-19 vaccine in nursing home residents
Torres, I., Albert, E., Gimenez, E., Alcaraz, M. J., Botija, P., Amat, P., Remigia, M. J., Beltran, M. J., Rodado, C., Huntley, D., Olea, B., Navarro, D.
10.1101/2021.04.19.21255723 — Posted: 2021-04-22
Prolonged activation of nasal immune cell populations and development of tissue-resident SARS-CoV-2 specific CD8 T cell responses following COVID-19
Roukens, A. H. E., Konig, M., Dalebout, T., Tak, T., Azimi, S., Kruize, Y., Pothast, C. R., Hagedoorn, R. S., Arbous, S. M., Zhang, J. L. H., Verheij, M., Prins, C., Does, A. M., Hiemstra, P. S., Vries, J. J. C., Janse, J. J., Roestenberg, M., Myeni, S. K., Kikkert, M., Heemskerk, M. H. M., Yazdanbakhsh, M., Smits, H. H., Jochems, S. P., BEAT-COVID group, , COVID-19 LUMC group
10.1101/2021.04.19.21255727 — Posted: 2021-04-22

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).